In the past week, ARMK stock has gone down by -5.03%, with a monthly decline of -4.93% and a quarterly plunge of -8.54%. The volatility ratio for the week is 3.05%, and the volatility levels for the last 30 days are 2.94% for Aramark The simple moving average for the past 20 days is -3.78% for ARMK’s stock, with a -7.11% simple moving average for the past 200 days.
Is It Worth Investing in Aramark (NYSE: ARMK) Right Now?
Aramark (NYSE: ARMK) has a higher price-to-earnings ratio of 26.91x compared to its average ratio. ARMK has 36-month beta value of 1.37. Analysts have mixed views on the stock, with 8 analysts rating it as a “buy,” 4 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for ARMK is 263.34M, and currently, short sellers hold a 1.88% ratio of that float. The average trading volume of ARMK on March 25, 2025 was 1.97M shares.
ARMK) stock’s latest price update
Aramark (NYSE: ARMK) has experienced a decline in its stock price by -0.76 compared to its previous closing price of 34.42. However, the company has seen a fall of -5.03% in its stock price over the last five trading days. businesswire.com reported 2025-03-24 that PHILADELPHIA–(BUSINESS WIRE)—- $ARMK–Aramark, (NYSE:ARMK), was honored on March 20th for its selection in the large, aggregated industry (Business, Education, Professional Services) category to the All-American Executive Team rankings by Extel (formerly Institutional Investor). “We are honored and humbled to receive this recognition from the Wall Street community,” said John Zillmer, Aramark CEO. “This award is a testament to the hard work of our more than 250,000 employees worldwide and the hospital.
Analysts’ Opinion of ARMK
Many brokerage firms have already submitted their reports for ARMK stocks, with Citigroup repeating the rating for ARMK by listing it as a “Buy.” The predicted price for ARMK in the upcoming period, according to Citigroup is $48 based on the research report published on February 24, 2025 of the current year 2025.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see ARMK reach a price target of $42.50, previously predicting the price at $36. The rating they have provided for ARMK stocks is “Outperform” according to the report published on September 17th, 2024.
Deutsche Bank gave a rating of “Buy” to ARMK, setting the target price at $39 in the report published on August 07th of the previous year.
ARMK Trading at -7.91% from the 50-Day Moving Average
After a stumble in the market that brought ARMK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.60% of loss for the given period.
Volatility was left at 2.94%, however, over the last 30 days, the volatility rate increased by 3.05%, as shares sank -8.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.30% lower at present.
During the last 5 trading sessions, ARMK fell by -5.03%, which changed the moving average for the period of 200-days by +6.75% in comparison to the 20-day moving average, which settled at $35.50. In addition, Aramark saw -8.44% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ARMK starting from Harrington Lauren A, who sale 7,909 shares at the price of $42.17 back on Nov 26 ’24. After this action, Harrington Lauren A now owns 89,447 shares of Aramark, valued at $333,523 using the latest closing price.
Harrington Lauren A, the Officer of Aramark, proposed sale 7,909 shares at $42.17 during a trade that took place back on Nov 26 ’24, which means that Harrington Lauren A is holding shares at $333,489 based on the most recent closing price.
Stock Fundamentals for ARMK
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.07 for the gross margin
The net margin for Aramark stands at 0.02. The total capital return value is set at 0.08. Equity return is now at value 11.46, with 2.70 for asset returns.
Based on Aramark (ARMK), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at 0.64. The debt to equity ratio resting at 0.4. The interest coverage ratio of the stock is 2.32.
Currently, EBITDA for the company is 1.17 billion with net debt to EBITDA at 0.62. When we switch over and look at the enterprise to sales, we see a ratio of 0.56. The receivables turnover for the company is 7.97for trailing twelve months and the total asset turnover is 1.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.94.
Conclusion
To put it simply, Aramark (ARMK) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
